As an upregulated IC in chronic lymphocytic leukemia, breast cancer (BC), non-small-cell lung cancer (NSCLC), and CRC, CD200 induces immunological tolerance by negatively regulating DCs, macrophages, and T cells that express its receptors37. Here, CD200 is linked to breast cancer.